tiprankstipranks
Solid Biosciences (SLDB)
NASDAQ:SLDB
US Market

Solid Biosciences (SLDB) Income Statement

Compare
1,242 Followers

Solid Biosciences Income Statement

Last quarter (Q3 2024), Solid Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Solid Biosciences's net income was $-32.73M. See Solid Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 8.09M$ 13.62M$ 0.00$ 0.00
Gross Profit
$ -76.56M$ 5.69M$ -45.12M$ -3.92M$ -2.82M
Operating Expenses
$ 104.31M$ 107.37M$ 85.87M$ 86.46M$ 119.32M
Depreciation and Amortization
$ 2.58M$ 2.41M$ 2.96M$ 3.92M$ 2.82M
EBITDA
$ -93.43M$ -96.87M$ -69.29M$ -84.37M$ -116.49M
Operating Income
$ -104.31M$ -106.45M$ -72.25M$ -88.41M$ -119.32M
Other Income/Expenses
$ 8.30M$ 20.47M$ 66.00K$ -1.83M$ 2.10M
Pretax Income
$ -96.02M$ -85.98M$ -72.19M$ -88.29M$ -117.22M
Net Income
$ -96.02M$ -65.51M$ -72.12M$ -90.12M$ -115.64M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -4.83$ -7.70$ -10.13$ -26.03$ -43.05
Diluted EPS
$ -4.83$ -7.70$ -10.13$ -26.03$ -43.05
Weighted Average Shares Outstanding
19.88M 8.51M 7.12M 3.46M 2.69M
Weighted Average Shares Outstanding (Diluted)
19.88M 8.51M 7.12M 3.46M 2.69M
Currency in USD

Solid Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis